Volume 84 Issue 9 | Cancer Research | American Association for Cancer Research
Cancer Research | 84 | 9 | May 2024
Cancer Research | 84 | 9 | May 2024
Statin use after breast cancer diagnosis may reduce the risk of cancer-specific death but does not appear to impact the risk of recurrence, a study…
The OncoAlert Newsletter is now out for June 23-29, 2023
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
In case you missed any, below is a recap of every episode of OncLive On Air that aired in April 2024.
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
In this segment, Dr. Shore will offer an overview of current treatment options for metastatic hormone-sensitive prostate cancer (mHSPC), as outlined in the NCCN Guidelines…
Abstract. BTK inhibitors (BTKis) are established standards of care in multiple B-cell malignancies including chronic lymphocytic leukemia, mantle cell lymp
The phase 2 DELLphi-301 trial showed durable response rates when tarlatamab was used to treat extensive-stage small cell lung cancer.
In research presented at the 2023 American Society of Hematology (ASH) Annual Meeting and Exposition, MD Anderson experts are sharing how different types of leukemia…
Melanoma is often detected later in people with darker skin complexions and the consequences can be devastating, a Mayo Clinic study reveals.